David Boulware to Pandemics
This is a "connection" page, showing publications David Boulware has written about Pandemics.
Connection Strength
0.098
-
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial. Ann Intern Med. 2020 10 20; 173(8):623-631.
Score: 0.030
-
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020 08 06; 383(6):517-525.
Score: 0.030
-
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial. Can J Anaesth. 2020 09; 67(9):1201-1211.
Score: 0.029
-
Finding the Dose for Hydroxychloroquine Prophylaxis for COVID-19: The Desperate Search for Effectiveness. Clin Pharmacol Ther. 2020 10; 108(4):766-769.
Score: 0.007
-
Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2. Crit Care. 2020 04 28; 24(1):182.
Score: 0.002